LifeStance Health Group, Inc.
LFST
$5.74
-$0.13-2.22%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 79.41% | 69.16% | 49.30% | 8.11% | 7.66% |
| Total Depreciation and Amortization | -25.96% | -11.79% | 1.80% | 10.13% | 15.64% |
| Total Amortization of Deferred Charges | -24.44% | -20.70% | -19.04% | -17.92% | -10.30% |
| Total Other Non-Cash Items | 4.01% | -0.92% | -40.77% | -37.66% | -38.03% |
| Change in Net Operating Assets | 62.27% | 18.85% | 60.06% | 47.52% | -82.45% |
| Cash from Operations | 508.69% | 735.28% | 2,657.44% | -59.00% | -174.13% |
| Capital Expenditure | 37.64% | 46.78% | 32.44% | 29.84% | 35.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 37.64% | 64.26% | 66.32% | 64.97% | 67.38% |
| Total Debt Issued | 398.34% | 398.34% | -26.97% | -39.71% | -75.66% |
| Total Debt Repaid | -11,011.89% | -11,620.40% | 65.98% | 64.20% | 98.62% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -24.90% | -5.17% | 27.22% | 29.42% | 71.39% |
| Cash from Financing | -135.06% | -120.97% | -14.71% | -36.05% | 72.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 550.49% | 354.21% | 225.73% | 143.11% | 58.76% |